MiNK Therapeutics, Inc. (NASDAQ:INKT) Q3 2025 Earnings Call Transcript November 14, 2025
MiNK Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.65, expectations were $-0.86.
Operator: Good morning, and welcome to MiNK Therapeutics, Inc. Third Quarter 2025 Conference Call and Webcast. Please note this event is being recorded. If anyone has any objections, you may disconnect at this time. I would now like to turn the conference over to Stephanie Perna Nacar, Chief...
